title: Safety aspects of subcutaneous immunotherapy with multiple allergens--a retrospective analysis on polysensitized patients.
abstract: Polysensitization against a multitude of different allergens is a common problem in the treatment of allergies with specific immunotherapy (SIT). The aim of this retrospective study was to investigate the risk of simultaneous administration of two allergen extracts during SIT with a conventional or Cluster regimen. Local (LR) and systemic reactions (SR) in 147 patients receiving different forms of SIT were compared. Patients received a total number of 2,758 injections during dose-increase phase and 3,412 injections during maintenance phase. During dose-increase phase, a higher rate of LR (for 1A 0.7% and for 2A 1.5%) was found with parallel injections of two allergen extracts (2A). The increase of SR was, however, not significant with conventional (for 1A 0% and for 2A 0.3%) or Cluster therapy (for 1A 0.3% and for 2A 0.5%). No increment of SR with injections of two allergen extracts did occur during maintenance phase (for 1A 0.3% and for 2A 0.1%). In conclusion, the results of the present study indicate that a higher rate of LR and SR must be considered during dose-increase phase independent of the kind of induction regime used. The rate of adverse events (AE) with two different allergen extracts, however, seems tolerable. After reaching maintenance phase, a higher rate of AE with parallel allergen injections did not occur.
authors.affiliation: Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. Christine.Barth@umm.de
authors.forename: C
authors.initials: C
authors.lastname: Barth
authors.forename: F
authors.initials: F
authors.lastname: Anero
authors.forename: O
authors.initials: O
authors.lastname: Pfaar
authors.forename: L
authors.initials: L
authors.lastname: Klimek
authors.forename: K
authors.initials: K
authors.lastname: Hörmann
authors.forename: B A
authors.initials: BA
authors.lastname: Stuck
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000485:Allergens / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D015331:Cohort Studies; D003888:Desensitization, Immunologic / Q000009:adverse effects* / Q000379:methods; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control*; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D055815:Young Adult
chemical_list: D000485:Allergens
references.citation: Int Arch Allergy Immunol. 2009;148(3):251-60
references.pmid: 18849616
references.citation: HNO. 2009 Nov;57(11):1099-105
references.pmid: 19585090
references.citation: N Engl J Med. 1999 Aug 12;341(7):468-75
references.pmid: 10441602
references.citation: Int Arch Allergy Immunol. 2003 Nov;132(3):258-62
references.pmid: 14646387
references.citation: Allergy. 2002 Apr;57(4):306-12
references.pmid: 11906360
references.citation: Thorax. 1999 Aug;54(8):675-80
references.pmid: 10413718
references.citation: J Allergy Clin Immunol. 2006 Jan;117(1):169-75
references.pmid: 16387602
references.citation: Eur Arch Otorhinolaryngol. 2010 Feb;267(2):245-50
references.pmid: 19756683
references.citation: Int J Epidemiol. 1986 Jun;15(2):202-9
references.pmid: 3721682
references.citation: Allergy. 2000 Sep;55(9):827-35
references.pmid: 11003446
references.citation: Laryngorhinootologie. 2003 Aug;82(8):558-63
references.pmid: 12915987
references.citation: Pediatr Allergy Immunol. 2008 Feb;19(1):67-75
references.pmid: 17651380
references.citation: J Investig Allergol Clin Immunol. 2004;14(4):312-9
references.pmid: 15736717
references.citation: Int Arch Allergy Immunol. 2001 May;125(1):57-65
references.pmid: 11385289
references.citation: Allergy. 2003 Dec;58(12):1261-7
references.pmid: 14616101
references.citation: J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):558-62
references.pmid: 9802362
references.citation: Clin Exp Allergy. 2007 Mar;37(3):434-40
references.pmid: 17359393
references.citation: Ann Allergy. 1960 Apr;18:427-34
references.pmid: 13824740
references.citation: J Allergy Clin Immunol. 2005 Jul;116(1):109-18
references.pmid: 15990782
references.citation: J Investig Allergol Clin Immunol. 2003;13(4):221-7
references.pmid: 14989109
references.citation: Eur Ann Allergy Clin Immunol. 2004 Feb;36(2):52-5
references.pmid: 15061395
references.citation: Clin Exp Allergy. 2004 Apr;34(4):527-31
references.pmid: 15080803
references.citation: Clin Exp Allergy. 2006 Apr;36(4):503-9
references.pmid: 16630156
references.citation: Clin Exp Allergy. 2002 Dec;32(12):1745-9
references.pmid: 12653166
references.citation: Allergy. 1993 Aug;48(6):450-3
references.pmid: 8238801
references.citation: Thorax. 2002 Oct;57 Suppl 2:II36-II39
references.pmid: 12364709
references.citation: J Allergy Clin Immunol. 1991 Mar;87(3):737-46
references.pmid: 2005328
references.citation: Ann Allergy Asthma Immunol. 2006 Aug;97(2):126-37; quiz 137-40, 202
references.pmid: 16937741
references.citation: Hautarzt. 2006 Oct;57(10):860-6
references.pmid: 16964477
references.citation: J Allergy Clin Immunol. 2002 Feb;109(2):251-6
references.pmid: 11842293
references.citation: Int Arch Allergy Immunol. 2009;150(1):102-8
references.pmid: 19339808
references.citation: Hautarzt. 2006 Oct;57(10):875-80
references.pmid: 16969674
references.citation: Int Arch Allergy Immunol. 2009;148(2):161-9
references.pmid: 18802361
references.citation: Clin Exp Allergy. 2006 Mar;36(3):254-60
references.pmid: 16499635